| Catalog Number |
06L21-25 |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
12/05/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Event or Problem Description
|
|
The customer reported (b)(6) architect havab-m results on one patient.The results provided for the patient diagnosed with waldenstrom's macroglobulinemia: (b)(6).There was no additional patient information provided.There was no reported impact to patient management.
|
| |
|
Additional Manufacturer Narrative
|
|
The customer observed erratic results for a patient diagnosed with waldenstrom's macroglobulinemia.A review of tickets determined that there were no additional complaints for lot 78085li00 and no trends were identified for the complaint issue.Historical performance of architect havab-m lot 78085li00 was evaluated using world wide data from abbott link.The overall median result across all lot numbers in the field during the reviewed timeframe is 0.18 s/co.The median patient result for lot 78085li00 is 0.17 s/co and indicates that the lot is performing in line with all other reagent lots.Manufacturing documentation for lot 78085li00 was reviewed and no contributing factors to the complaint could be identified.A review of labeling concluded that the issue is sufficiently addressed.Patients suffering from waldenstrom's macroglobulinemia show increased levels of monoclonal immunugobulins (usually igm) in the serum.Waldenstrom's macroglobulinemia belongs to the group of non-hodgkin's lymphomas and the architect havab-m reagent package insert states that specimens from individuals with non-hodgkin's lymphoma may cross-react with this assay.Based on the investigation no product deficiency was identified for architect havab-m, lot 78085li00.
|
| |
|
Search Alerts/Recalls
|